CPT 92608 Speech-Generating Device Reimbursement

CPT code 92608 represents a time‑based, clinician‑delivered extension (an additional 30 minutes) of the evaluation process for prescribing a speech‑generating device. This code captures specialized assessment activities: direct patient interaction, standardized and functional testing of communication abilities, and preparation of a detailed report describing device needs and recommended strategies. Nationally, accurate reporting of 92608 supports appropriate recognition of extended clinical time and complexity in augmentative and alternative communication (AAC) services and informs payment for multidisciplinary care for patients with significant speech impairments.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of what 92608 denotes clinically, payer scope included in the analysis, and the types of benchmarks and policy details typically relevant to this service. The publication outlines clinical context for AAC device evaluation, common places the service is delivered, coding relationships that affect billing and documentation, and the types of metrics payers and programs use to assess coverage and utilization. Where input data is missing, the text notes that information is not available rather than speculating. The piece is intended to inform billing staff, speech‑language pathologists, and policy analysts about the national significance and practical reporting considerations for CPT code 92608.

Billing Code Overview

CPT code 92608 describes an additional 30 minutes of provider evaluation for prescription of a speech‑generating device delivered in the same session after an initial hour. The service involves direct interaction with the patient, administration of tests and assessments of functional communication ability, and preparation of a detailed report documenting the patient’s communication skills and recommended techniques or device features.

Service type: Extended evaluation for assistive communication device prescription
Typical site of service: Outpatient clinic, rehabilitation facility, specialty speech‑language pathology clinic, or other ambulatory settings where speech‑language pathology evaluations are performed

Data not available in the input.

Clinical Context

A 62-year-old patient with progressive bulbar amyotrophic lateral sclerosis (ALS) presents to a speech-language pathologist for advanced augmentative and alternative communication (AAC) assessment. The patient has severe dysarthria and deteriorating oral-motor control, limiting functional speech. During a single extended outpatient session, the provider performs an initial comprehensive evaluation of intelligibility, expressive language skills, cognition, and motor control using standardized tests and functional communication tasks, followed by an additional 30-minute period dedicated to selection and programming of a speech–generating device (SGD), trials with various access methods (touch, switch, eye-gaze), caregiver training, and documentation. The workflow includes chart review, device trials, measurement of rate and accuracy, customization of vocabulary and access settings, demonstration of device use, and preparation of a detailed report supporting device prescription, funding requests, and medical necessity.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when reporting only the professional component of the evaluation if a separate technical component is billed by another entity.
`52`

Taxonomy Code	Specialty	Notes
124Q00000X	Speech-Language Pathology	Primary providers who perform SGD evaluation and device prescription.
103T00000X	Occupational Therapy	Commonly involved for access method assessment and environmental/device mounting considerations.
207L00000X	Physical Therapy	Involved when motor control or positioning affects access to the SGD.
363A00000X	Assistive Technology Services	Clinicians specializing in device procurement, customization, and training.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`R47.1`	Dysphasia and aphasia	Language impairment that may necessitate an SGD evaluation to restore functional communication.
`R47.02`	Dysarthria	Motor-speech disorder commonly indicating need for a speech-generating device when intelligibility is poor.
`G12.21`	Amyotrophic lateral sclerosis	Progressive neuromuscular disease frequently associated with loss of speech, supporting SGD prescription.
`G35`	Multiple sclerosis	Neurodegenerative disease that can cause severe speech and swallowing impairment prompting SGD consideration.
`I69.391`	Dysarthria following cerebral infarction	Post-stroke motor-speech impairment where SGD evaluation aids communication rehabilitation.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`92607`	Evaluation for prescription for speech-generating device, first 60 minutes	Represents the initial hour of the SGD evaluation that precedes the additional 30-minute service billed with `92608`.
`92609`	Treatment of speech, language, voice, communication, and/or auditory processing disorder; communicative training for the use of speech-generating device, per 15 minutes	Used for ongoing training sessions teaching patient and caregivers to use the prescribed SGD after the evaluation and prescription.
`97530`	Therapeutic activities, direct (one-on-one) patient contact by the provider, each 15 minutes	Used when occupational or physical therapy provides therapeutic activities supporting access and functional use of the SGD.
`92626`	Evaluation of speech and language (e.g., for augmentative and alternative communication)	Used for broader speech and language evaluation that may be performed prior to or in conjunction with an SGD-specific assessment.

OpenPayer

Summary & Overview

CPT 92608: Additional 30-Minute Evaluation for Speech-Generating Device